SGLT2 inhibitors vs GLP-1 receptor agonists and clinical outcomes in patients with diabetes with/without atrial fibrillation
How Many Adults with Private Health Insurance Could Use GLP-1 Drugs More than two in five (42%) or 57.4 million adults under 65 with private insurance could be eligible under clinical criteria for GLP-1 drugs used to treat people with type 2 diabetes, obesity, or excess weight and weight-related health issues, according to a new KFF analysis
Just give it time and the right environment
Chemical peels : Chemical peels are applied to the skin to remove the outer layers, promoting new skin growth and reducing pigmentation, resulting in a lighter skin tone
Why the new trial matters The TAG-MS trial, reported by Multiple Sclerosis News Today on May 7, is structured to address the mechanism question directly
Garlic may also increase the bioaccessibility of iron and zinc (both antagonists of cadmium and lead absorption) from dietary cereal grains